3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Nonhematologic Malignancies
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Somatostatinoma
1
Sarcoma, Synovial
1
Sarcoma
1
Recurrent Lung Squamous Cell Carcinoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Non-hematologic Malignancy
1
Neurofibrosarcoma
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer
1
Meningeal Neoplasms
1
Lymphoma
1
Liver Neoplasms
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hematologic Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Interventions
Temozolomide
47
Bevacizumab
41
Radiotherapy
17
Magnetic Resonance Spectroscopy
14
Irinotecan
11
Nivolumab
8
Everolimus
7
Radiation
6
poly ICLC
5
X-Rays
5
Phantoms, Imaging
5
Carboplatin
5
pembrolizumab
4
fluorodopa F 18
4
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Erlotinib Hydrochloride
4
Carmustine
4
ribociclib
3
palbociclib
3
ivosidenib
3
antineoplaston A10
3
Vorinostat
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
Modafinil
3
Lomustine
3
Biopsy
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Glioma
×
sapanisertib
×
Clear all
No trials found.